Buccal Misoprostol and Intravenous Tranexamic Acid During Emergent Cesarean Delivery

• Status: Unknown status
• Trial end date: 2021-01-31
• Target enrollment: 0
• Participant gender: Female

Summary

Purpose to evaluate the effects of buccal misoprostol with or without intravenous tranexamic acid (TA) in comparison with placebo on reducing post-partum hemorrhage in pregnant women undergoing emergent cesarean section

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: hany farouk
• Treatments: Misoprostol; Tranexamic Acid

Criteria

Inclusion Criteria:

• age >18 years, singleton pregnancy, term gestation and decision made for a cesarean section in labor

Exclusion Criteria:

• multiple gestations

• placenta praevia and placental abruption

• undergoing cesarean section with general anesthesia

• women undergoing cesarean section at less than 37 weeks of gestation--with a severe medical disorder

• allergy to tranexamic acid or misoprostol

• refuse to consent

• elective cesarean section